Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers - SciAlert Responsive Version
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single
Ovarian tumor markers: What to draw and when | MDedge ObGyn
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CA 19-9 – Pancreatic Cancer Action Network
Patient selection criteria. GB, gallbladder; CA 19-9, carbohydrate... | Download Scientific Diagram
CA 19-9: handle with care
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. - Abstract - Europe PMC
PDF) Pancreatic Cancer with Normal CA 19-9 and Lewis Antigen Negative-Case Report | Journal of Pharmacy and Pharmacology - Academia.edu
Southwest Journal of Pulmonary, Critical Care and Sleep - Pulmonary - Elevated Tumor Markers In Coccidioidomycosis of the Female Genital Tract
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
CA19-9 - Wikipedia
Clinical Significance of Tumour Markers | Semantic Scholar
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
![PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a96fc01f495907ea18214fdc7db7ffd9b210d72c/2-TableI-1.png "PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar")